See all results

Coronavirus (COVID-19) Updates

For the latest COVID-19 information and updates from Qatar Foundation, please visit our Statements page

September 30, 2018

Sidra Medicine Concludes CUDOS 2018 Conference

Over 400 researchers, healthcare professionals, exhibitors, VIPs and international speakers gathered at the second Conference on Diabetes, Obesity, Cardiovascular Diseases and Stroke (CUDOS 2018) hosted by Sidra Medicine, a member of Qatar Foundation (QF), from September 22-24.
With its theme being ‘Childhood Diabetes: from Novel Discoveries to Clinical Practice’, the three-day conference concluded with high-profile presentations and discussions on addressing diabetes challenges in children and women. Professor the Lord Darzi of Denham, Vice Chair, Sidra Medicine highlighted how CUDOS 2018 is rooted in developing practical and implementable improvements in care – keeping the needs of the patients in mind.
In addition to establishing several local and international collaborations with partners, a key outcome from CUDOS 2018 was the recognition of three young investigators – Mr. Omair Al Naeemi, Ms. Reem Hasna and Mr. Mohamed Ibrahim Janahi. They were awarded by Professor Christof von Kalle, Chief Research Officer, Sidra Medicine, and Dr. Ammira-Sarah Akil, Staff Scientist and CUDOS 2018 Conference Chairperson and Organizer, for their outstanding presentations on medical sciences.
Local keynote speakers included Sheikh Dr. Mohamed Bin Hamad Bin J. Al-Thani, Director of Public Health at the Ministry of Public Health, who highlighted the investment Qatar is making in addressing diabetes and how CUDOS 2018 brought together local and international experts committed to optimizing the health of children and adults with diabetes. Ms. Reem Al-Mansoori, Assistant Undersecretary for Digital Society Development at the Ministry of Transport and Communications, discussed the ministry’s Smart Qatar Healthcare initiative.
“CUDOS 2018 was an excellent showcase of how the healthcare network and corporate partners can collaborate on a common goal – advancing programs that will benefit the people of Qatar,” said Dr. Akil.

Dr. Abdulla Al Ansari, Acting Chief Medical Officer, Hamad Medical Corporation, said the conference, which focused on two of Qatar’s greatest public health challenges, provided an important opportunity to explore the prevention and treatment of metabolic diseases beyond the clinical setting. “Diabetes and obesity are among the greatest threats facing health and well-being in Qatar,” he said.
“This conference brought together an interdisciplinary group of professionals working in the fields of diabetes and childhood obesity and provided an important platform to explore the role healthcare professionals play in promoting strategies which enhance the well-being of children living with, or at risk of, these metabolic diseases.”

To read more, please click here.